The clinical application value of the biomarkers based on autophagy screening in the diagnosis and monitoring of inflammatory bowel disease in pediatric patients
• BCL2L1 was an IRF for the occurrence and disease activity of pediatric IBD. • BCL2L1 had high clinical application value in assisting pediatric IBD diagnosis and predicting disease activity.
Authors
- Xiaolu Nie (ORCID: https://orcid.org/0000-0001-8026-7845)
- Yan Kong (ORCID: https://orcid.org/0000-0001-6020-1419)
- Xiaohong Xu (ORCID: https://orcid.org/0009-0007-3610-0395)
- Jie Wu (ORCID: https://orcid.org/0000-0003-4028-6173)
- Xiaolin Ye (ORCID: https://orcid.org/0000-0003-0086-0601)
- Tianzhuo Zhang
Institutions
- Beijing Children’s Hospital (CN)
Publication Details
- Journal
- European Journal of Pediatrics
- Published
- 2025-06-09
- DOI
- https://doi.org/10.1007/s00431-025-06213-6
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China